Qiu Y, Guo H, Wang S, Yang S, Peng X, Xiayao D
BMC Med Inform Decis Mak. 2024; 24(1):225.
PMID: 39118118
PMC: 11308714.
DOI: 10.1186/s12911-024-02616-x.
Chollet L, Iqbal S, Wittmer S, Thalmann G, Madaffari A, Kozhuharov N
Europace. 2024; 26(4).
PMID: 38597211
PMC: 11004789.
DOI: 10.1093/europace/euae071.
Pozios I, Vouliotis A, Dilaveris P, Tsioufis C
J Cardiovasc Dev Dis. 2023; 10(4).
PMID: 37103028
PMC: 10141162.
DOI: 10.3390/jcdd10040149.
Labarbera M, Atta-Fosu T, Feeny A, Firouznia M, Mchale M, Cantlay C
IEEE J Transl Eng Health Med. 2022; 10:1800209.
PMID: 34976444
PMC: 8716081.
DOI: 10.1109/JTEHM.2021.3134160.
Muller P, Weijs B, Bemelmans N, Mugge A, Eckardt L, Crijns H
Clin Res Cardiol. 2021; 110(11):1734-1742.
PMID: 34453577
PMC: 8563556.
DOI: 10.1007/s00392-021-01917-9.
Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score.
Seewoster T, Buttner P, Zeynalova S, Hindricks G, Kornej J
Clin Cardiol. 2020; 43(7):762-768.
PMID: 32462768
PMC: 7368300.
DOI: 10.1002/clc.23378.
Association Between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical Substrate and NT-proANP Levels in Atrial Fibrillation.
Seewoster T, Buttner P, Nedios S, Sommer P, Dagres N, Schumacher K
J Am Heart Assoc. 2018; 7(19):e009427.
PMID: 30371296
PMC: 6404891.
DOI: 10.1161/JAHA.118.009427.
Echocardiography In the Prediction of Atrial Fibrillation Recurrence: A Review.
Caputo M, Mondillo S
J Atr Fibrillation. 2017; 5(2):675.
PMID: 28496764
PMC: 5153127.
DOI: 10.4022/jafib.675.
Left atrial volume assessment in atrial fibrillation using multimodality imaging: a comparison of echocardiography, invasive three-dimensional CARTO and cardiac magnetic resonance imaging.
Rabbat M, Wilber D, Thomas K, Malick O, Bashir A, Agrawal A
Int J Cardiovasc Imaging. 2015; 31(5):1011-8.
PMID: 25761533
DOI: 10.1007/s10554-015-0641-y.
